ES2053014T5 - El retrovirus sivcpz-ant y sus usos. - Google Patents

El retrovirus sivcpz-ant y sus usos.

Info

Publication number
ES2053014T5
ES2053014T5 ES90111364T ES90111364T ES2053014T5 ES 2053014 T5 ES2053014 T5 ES 2053014T5 ES 90111364 T ES90111364 T ES 90111364T ES 90111364 T ES90111364 T ES 90111364T ES 2053014 T5 ES2053014 T5 ES 2053014T5
Authority
ES
Spain
Prior art keywords
ant
lymphocytes
protein
retrovirus
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90111364T
Other languages
English (en)
Other versions
ES2053014T3 (es
Inventor
Peter Prof Dr Piot
Der Groen Guido Dr Sc Van
Eric Dr Delaporte
Martine Dr Peeters
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Europe NV SA
Original Assignee
Innogenetics NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8204103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2053014(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Innogenetics NV SA filed Critical Innogenetics NV SA
Application granted granted Critical
Publication of ES2053014T3 publication Critical patent/ES2053014T3/es
Publication of ES2053014T5 publication Critical patent/ES2053014T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA INVENCION ACTUAL SE REFIERE A UN RETROVIRUS AISLADO DE UN CHIMPACE Y DESIGNADO COMO SIV SUB CPZ-ANT Y A LAS VARIANTES DE ESTE VIRUS, PROVISTO DE LAS SIGUIENTES PROPIEDADES ESENCIALES MORFOLOGICAS E INMUNOLOGICAS: PARA T4 LINFOCITOS. TIPICO CON LA FORMACION DE CELULAS GIGANTES EN LOS LINFOCITOS QUE INFECTA, NM, PTASA DEPENDIENTE DEL MAGNESIO, ELULARES INMORTALIZADAS PORTADORAS DEL RECEPTOR T4, DOS DEL VIRUS CONTIENEN UNA PROTEINA P27 DISTINTA INMUNOLOGICAMENTE DE LA P25 DEL HIV-1 Y DE LA PROTEINA P19 DEL HTLV-1 SEGUN LOS ANALISIS DE MANCHAS DEL OESTE, NTIENEN UNA PROTEINA GP140 INMUNOLOGICAMENTE DISTINTA DE LA GP120 DEL HIV-1 Y DE LA GP110 DEL HTLV-1 SEGUN LOS ANALISIS DE MANCHAS DEL OESTE, UNA GLICOPROTEINA TRANSMEMBRANOSA CON UN PESO MOLECULAR DE 44.000 A 50.000 KD.
ES90111364T 1990-06-15 1990-06-15 El retrovirus sivcpz-ant y sus usos. Expired - Lifetime ES2053014T5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90111364A EP0494317B2 (en) 1990-06-15 1990-06-15 The retrovirus SIV cpz-ant and its uses

Publications (2)

Publication Number Publication Date
ES2053014T3 ES2053014T3 (es) 1994-07-16
ES2053014T5 true ES2053014T5 (es) 2001-02-16

Family

ID=8204103

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90111364T Expired - Lifetime ES2053014T5 (es) 1990-06-15 1990-06-15 El retrovirus sivcpz-ant y sus usos.

Country Status (10)

Country Link
US (1) US5624795A (es)
EP (1) EP0494317B2 (es)
JP (1) JPH06500230A (es)
AT (1) ATE105857T1 (es)
AU (1) AU657479B2 (es)
CA (1) CA2085370A1 (es)
DE (1) DE69009066T3 (es)
DK (1) DK0494317T4 (es)
ES (1) ES2053014T5 (es)
WO (1) WO1991019785A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470572A (en) * 1993-07-16 1995-11-28 University Of Puerto Rico Non-infectious simian immunodeficiency virus particles produced by cell line CRL 11393
WO2003062377A2 (en) * 2002-01-17 2003-07-31 The Uab Research Foundation COMPLETE GENOME SEQUENCE OF SIVcpzTAN1
CN102985536B (zh) 2010-04-14 2017-12-05 Emd密理博公司 生产高效价、高纯度的病毒母液的方法及使用其的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3588254T2 (de) 1984-10-18 2008-06-26 Institut Pasteur GAG-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen
ATE47725T1 (de) 1986-01-22 1989-11-15 Pasteur Institut Zum hervorrufen von aids geeigneter retrovirus vom typ hiv-2, sowie seine antigen- und nukleinsaeure-bestandteile.
WO1989009815A1 (en) * 1988-04-04 1989-10-19 Research Corporation Technologies, Inc. Novel virus of the hiv-2 family and methods of detection therefor
EP0657532B1 (en) * 1988-06-09 2003-12-17 N.V. Innogenetics S.A. HIV-3 retrovirus strains and their use
FR2644176B1 (fr) 1989-03-07 1993-10-08 Franceville Ctre Internal Recher Retrovirus viscpz infectant naturellement le chimpanze, fragments d'adn de ce retrovirus, procede de preparation d'une proteine et/ou d'une enzyme de ce virus et leurs utilisations

Also Published As

Publication number Publication date
EP0494317A1 (en) 1992-07-15
DE69009066T2 (de) 1994-10-06
ES2053014T3 (es) 1994-07-16
CA2085370A1 (en) 1991-12-16
ATE105857T1 (de) 1994-06-15
DE69009066T3 (de) 2001-07-19
DK0494317T3 (da) 1994-10-10
WO1991019785A1 (en) 1991-12-26
US5624795A (en) 1997-04-29
EP0494317B1 (en) 1994-05-18
DK0494317T4 (da) 2001-04-02
AU657479B2 (en) 1995-03-16
EP0494317B2 (en) 2000-12-27
JPH06500230A (ja) 1994-01-13
DE69009066D1 (de) 1994-06-23
AU7967091A (en) 1992-01-07

Similar Documents

Publication Publication Date Title
Dettenhofer et al. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions
FI903866A0 (fi) Terapeutiskt aktiva albuminderivat.
ES2126620T3 (es) Retrovirus del grupo de los vih y su utilizacion.
PE43298A1 (es) Genes sinteticos de vih
DE3650377D1 (de) Regulierung der retroviralen replikation, infektion und pathogenese.
ES2104556T3 (es) Peptidos que tienen propiedades inmunologicas de hiv-2.
ES2153654T3 (es) Vectores retrovirales.
DK2267452T3 (da) Opløseligt kompleks omfattende et retroviralt overfladeglycoprotein
Costa et al. Interactions between Nef and AIP1 proliferate multivesicular bodies and facilitate egress of HIV-1
ATE264914T1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
EA200300336A1 (ru) Пептиды вич, антигены, вакцинные композиции, набор для иммуноанализа и способ обнаружения антител, индуцируемых вич
ES2083353T3 (es) Sistema infectivo de liberacion de farmacos.
DE69936577D1 (de) Lentivirale Verpackungszellen
ES2134197T3 (es) Vacunas contra el virus del herpes simplex vp16.
ES2066887T3 (es) Anticuerpo monoclonal para diferenciar individuos seropositivos hiv-2 de los hiv-1.
Vidricaire et al. Endocytic host cell machinery plays a dominant role in intracellular trafficking of incoming human immunodeficiency virus type 1 in human placental trophoblasts
ES2053014T5 (es) El retrovirus sivcpz-ant y sus usos.
Berkower et al. A predominant group-specific neutralizing epitope of human immunodeficiency virus type 1 maps to residues 342 to 511 of the envelope glycoprotein gp120
ES2058259T3 (es) Antigenos sinteticos para la deteccion de enfermedad relacionada con sida causada por lav-2.
ES2137378T3 (es) Estructuras peptidicas poliramificadas para ser utilizadas contra el hiv.
FI903976A0 (fi) Gener och av dessa kodade proteiner som regulerar genexpression av interleukin-2-receptor och humana lymfotropiska retrovirus.
ES2195200T3 (es) Construccion de peptidos de rama multiples.
ES2113860T3 (es) Peptidos con grupos tioles de cisteina protegidos, utiles en los ensayos inmunologicos.
ES2095899T3 (es) Peptidos de la proteina gag de vih, su preparacion y uso.
DE68925191D1 (de) Peptide mit schutzeigenschaften gegen ein pathogenes virus des hiv-typs in sensitiven zellen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 494317

Country of ref document: ES